Ascendis Pharma A/S Cash Flows From Used In Investing Activities
Ascendis Pharma A/S (ASND) reported Cash Flows From Used In Investing Activities of -EUR 8.48 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-02-11
- Ascendis Pharma A/S cash flows from used in investing activities for the quarter ending 2025-12-31 was -3.39M EUR.
- Ascendis Pharma A/S cash flows from used in investing activities for the quarter ending 2025-09-30 was -53.00K EUR.
- Ascendis Pharma A/S cash flows from used in investing activities for the quarter ending 2025-06-30 was -4.34M EUR, a 813.49% decline year-over-year.
- Ascendis Pharma A/S cash flows from used in investing activities for the quarter ending 2025-03-31 was -703.00K EUR, a 109.83% decline year-over-year.
| Period end | Cash Flows From Used In Investing Activities 3 month | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 9 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | -3.39M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -3.44M EUR derived: sum of 2 quarters · filed 2026-02-11 | -7.78M EUR derived: sum of 3 quarters · filed 2026-02-11 | -8.48M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | -53.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | -4.39M EUR derived: sum of 2 quarters · filed 2025-11-12 | -5.09M EUR 6-K · filed 2025-11-12 | -5.48M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | -4.34M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | -5.04M EUR 6-K · filed 2025-08-07 | -5.42M EUR derived: sum of 3 quarters · filed 2026-02-11 | -5.93M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | -703.00K EUR 6-K · filed 2025-05-01 | -1.09M EUR derived: sum of 2 quarters · filed 2026-02-11 | -1.59M EUR derived: sum of 3 quarters · filed 2026-02-11 | -982.00K EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | -384.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | -887.00K EUR derived: sum of 2 quarters · filed 2026-02-11 | -279.00K EUR derived: sum of 3 quarters · filed 2026-02-11 | 6.88M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | -503.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 105.00K EUR derived: sum of 2 quarters · filed 2025-11-12 | 7.26M EUR 6-K · filed 2025-11-12 | 13.91M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | 608.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 7.76M EUR 6-K · filed 2025-08-07 | 14.41M EUR derived: sum of 3 quarters · filed 2026-02-11 | 36.63M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | 7.16M EUR 6-K · filed 2025-05-01 | 13.81M EUR derived: sum of 2 quarters · filed 2026-02-11 | 36.03M EUR derived: sum of 3 quarters · filed 2026-02-11 | 82.98M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | 6.65M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 28.87M EUR derived: sum of 2 quarters · filed 2026-02-11 | 75.83M EUR derived: sum of 3 quarters · filed 2026-02-11 | 286.47M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | 22.22M EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-14 | 69.18M EUR derived: sum of 2 quarters · filed 2024-11-14 | 279.82M EUR 6-K · filed 2024-11-14 | 279.03M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | 46.96M EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-09-03 | 257.60M EUR 6-K · filed 2024-09-03 | 256.81M EUR derived: sum of 3 quarters · filed 2025-02-12 | 270.90M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | 210.65M EUR 6-K · filed 2024-05-02 | 209.85M EUR derived: sum of 2 quarters · filed 2025-02-12 | 223.95M EUR derived: sum of 3 quarters · filed 2025-02-12 | 233.84M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -797.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 13.30M EUR derived: sum of 2 quarters · filed 2025-02-12 | 23.19M EUR derived: sum of 3 quarters · filed 2025-02-12 | 61.73M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | 14.10M EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 23.99M EUR derived: sum of 2 quarters · filed 2023-11-07 | 62.53M EUR 6-K · filed 2023-11-07 | -49.39M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | 9.89M EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | 48.43M EUR 6-K · filed 2023-09-05 | -63.49M EUR derived: sum of 3 quarters · filed 2024-02-07 | -43.07M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 38.54M EUR 6-K · filed 2023-04-27 | -73.38M EUR derived: sum of 2 quarters · filed 2024-02-07 | -52.95M EUR derived: sum of 3 quarters · filed 2024-02-07 | -41.92M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | -111.92M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | -91.50M EUR derived: sum of 2 quarters · filed 2024-02-07 | -80.46M EUR derived: sum of 3 quarters · filed 2024-02-07 | -110.58M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 20.43M EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-02 | 31.46M EUR derived: sum of 2 quarters · filed 2022-11-02 | 1.34M EUR 6-K · filed 2022-11-02 | -69.79M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | 11.04M EUR derived: 6-K 6 month − 6-K 3 month · filed 2022-08-10 | -19.08M EUR 6-K · filed 2022-08-10 | -90.21M EUR derived: sum of 3 quarters · filed 2023-02-16 | -65.80M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -30.12M EUR 6-K · filed 2022-05-11 | -101.25M EUR derived: sum of 2 quarters · filed 2023-02-16 | -76.83M EUR derived: sum of 3 quarters · filed 2023-02-16 | -315.18M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -71.13M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | -46.72M EUR derived: sum of 2 quarters · filed 2023-02-16 | -285.06M EUR derived: sum of 3 quarters · filed 2023-02-16 | -291.20M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | 24.41M EUR derived: 6-K 9 month − 6-K 6 month · filed 2021-11-10 | -213.93M EUR derived: sum of 2 quarters · filed 2021-11-10 | -220.07M EUR 6-K · filed 2021-11-10 | -221.20M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | -238.34M EUR derived: 6-K 6 month − 6-K 3 month · filed 2021-08-27 | -244.48M EUR 6-K · filed 2021-08-27 | -245.61M EUR derived: sum of 3 quarters · filed 2022-03-02 | -246.86M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | -6.14M EUR 6-K · filed 2021-05-27 | -7.27M EUR derived: sum of 2 quarters · filed 2022-03-02 | -8.52M EUR derived: sum of 3 quarters · filed 2022-03-02 | -8.83M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | -1.13M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | -2.38M EUR derived: sum of 2 quarters · filed 2022-03-02 | -2.69M EUR derived: sum of 3 quarters · filed 2022-03-02 | -5.16M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | -1.25M EUR derived: 6-K 9 month − 6-K 6 month · filed 2020-11-12 | -1.56M EUR derived: sum of 2 quarters · filed 2020-11-12 | -4.03M EUR 6-K · filed 2020-11-12 | -5.09M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | -311.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2020-08-27 | -2.78M EUR 6-K · filed 2020-08-27 | -3.84M EUR derived: sum of 3 quarters · filed 2021-03-10 | -4.99M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | -2.47M EUR 6-K · filed 2020-05-19 | -3.53M EUR derived: sum of 2 quarters · filed 2021-03-10 | -4.68M EUR derived: sum of 3 quarters · filed 2021-03-10 | -5.01M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | -1.06M EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | -2.21M EUR derived: sum of 2 quarters · filed 2021-03-10 | -2.55M EUR derived: sum of 3 quarters · filed 2021-03-10 | -2.65M EUR 20-F · filed 2021-03-10 |
| 2018-09-30 | -1.15M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-11-18 | -1.49M EUR derived: sum of 2 quarters · filed 2019-11-18 | -1.59M EUR 6-K · filed 2019-11-18 | -1.82M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | -335.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-08-28 | -437.00K EUR 6-K · filed 2019-08-28 | -672.00K EUR derived: sum of 3 quarters · filed 2020-04-03 | -793.00K EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | -102.00K EUR 6-K · filed 2019-05-30 | -337.00K EUR derived: sum of 2 quarters · filed 2020-04-03 | -458.00K EUR derived: sum of 3 quarters · filed 2020-04-03 | -666.00K EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | -235.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | -356.00K EUR derived: sum of 2 quarters · filed 2020-04-03 | -564.00K EUR derived: sum of 3 quarters · filed 2020-04-03 | -941.00K EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | -121.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-11-28 | -329.00K EUR derived: sum of 2 quarters · filed 2018-11-28 | -706.00K EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | -208.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-29 | -585.00K EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | -377.00K EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | -672.00K EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | -1.04M EUR 20-F · filed 2018-03-28 |